Equities

Nanjing Vishee Medical Technology Co Ltd

688580:SHH

Nanjing Vishee Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)30.29
  • Today's Change-0.61 / -1.97%
  • Shares traded994.78k
  • 1 Year change-37.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nanjing Vishee Medical Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of rehabilitation medical equipment and products. The Company’s products are mainly electrical stimulation, magnetic stimulation, electrophysiological equipment, consumables and accessories and other rehabilitation medical equipment and products, such as pelvic floor muscle recovery equipment, transcranial magnetic stimulator, neonatal electroencephalography measuring instrument, rectal electrode, micro current stimulator and others. The Company mainly conducts its businesses within the domestic market.

  • Revenue in CNY (TTM)422.21m
  • Net income in CNY112.74m
  • Incorporated2001
  • Employees700.00
  • Location
    Nanjing Vishee Medical Technology Co LtdBlock 9#19 Ningshuang Road, Yuhuatai DistrictNANJING 210012ChinaCHN
  • Phone+86 2 569670036
  • Fax+86 2 569670037
  • Websitehttp://www.vishee.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nanjing Medlander Medical Tech Co Ltd380.95m101.15m2.55bn481.0024.921.95--6.701.021.023.8613.100.25271.9821.47791,989.407.06--7.76--71.46--27.94--7.57--0.0115---9.57---26.19------
Chemclin Diagnostics Co Ltd443.86m139.29m2.85bn731.0020.452.04--6.430.34760.34761.113.490.24911.0016.34607,195.307.8211.018.7312.3274.8974.1931.3831.075.16--0.151536.64-4.284.00-3.44--44.10--
Cowealth Medical China Co Ltd970.41m29.67m2.90bn240.0097.692.48--2.990.07450.07452.442.930.64353.901.254,043,355.002.015.802.598.0919.6220.743.136.143.65--0.082923.89-14.623.85-42.96-6.7532.85--
Nanjing Vishee Medical Technology Co Ltd422.21m112.74m2.90bn700.0025.641.80--6.871.181.184.4216.830.24013.1212.37603,153.406.4110.276.9211.4370.2173.2626.7033.998.31--0.000347.5743.7217.3445.2216.5526.69--
Beijing Succeeder Technology Inc297.74m112.75m2.94bn296.0026.101.80--9.861.061.062.8015.410.17662.518.661,005,870.006.697.777.028.2560.3961.0337.8538.3414.78--0.0000422.2220.406.6012.2915.5799.03--
Beijing Hotgen Biotech Co Ltd520.50m-67.64m2.98bn1.04k--0.9132--5.72-0.7349-0.73495.7435.250.14842.205.85502,410.60-2.1329.65-2.2234.7046.9856.08-14.3332.268.95--0.002641.92-84.7823.67-97.10-10.6757.98--
Hangzhou Biotest Biotech Co Ltd518.65m104.29m3.20bn629.0030.271.35--6.160.98970.98974.9422.270.2042.616.85824,563.604.0129.454.2333.3052.4256.8319.6441.5912.53--0.000329.32-76.7519.65-86.2241.3334.82--
Data as of Nov 15 2024. Currency figures normalised to Nanjing Vishee Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

15.39%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 30 Jun 20242.54m10.24%
Penghua Fund Management Co., Ltd.as of 30 Jun 2024609.86k2.46%
JX Asset Management Co.,Ltdas of 30 Jun 2024212.80k0.86%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024102.19k0.41%
China Merchants Fund Management Co., Ltd.as of 30 Jun 202493.57k0.38%
Huashang Fund Management Co., Ltd.as of 30 Jun 202492.42k0.37%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 202473.84k0.30%
China Southern Asset Management Co., Ltd.as of 30 Jun 202454.31k0.22%
Gfund Management Co., Ltd.as of 30 Jun 202418.20k0.07%
CCB Principal Asset Management Co., Ltd.as of 30 Jun 202417.00k0.07%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.